AYUSH ministry to enter agreement with WHO to popularise AYUSH
Advertisement
New Delhi: To popularise AYUSH system of medicine across the world, the ministry will enter into an agreement with WHO and a partnership with United States for research in AYUSH medicines for treatment of cancer.
"AYUSH is a very important sector and it should be propagated worldwide. MoUs have already been signed with several countries for bilateral cooperation in the field of traditional medicine.
"In view of the suggestions received, the National Health Policy would be reviewed in the next six months to incorporate this aspect of propagation of AYUSH. India is also entering into a very important partnership with the United States for research in AYUSH for treatment of cancer," AYUSH minister Shripad Yesso Naik said.
He was speaking after inaugurating the National Arogya Fair at Auto Cluster Development and Research Institute (ACDRI), PCMC, Chinchwad in Pune.
The Arogya fair aims to create awareness among the people about efficiency of the AYUSH Systems, their cost effectiveness and the availability of herbs and plants used for prevention and treatment of common ailments.
The fair is showcasing sectors like Ayurveda, Sidha, Naturopathy, Yoga, Unani, Homeopathy and other recognized traditional healthcare systems.
Institutions, companies associated with these areas of health care including insurance, health tourism, lab equipment and machinery, research institutes, hospitals, naturopathy centres are taking part in the event.
Central Research Councils and National Institute in the AYUSH Systems of Medicine along with the National Medicinal Plant Board (NMPB), Indian Medicines Pharmaceutical Corporations Limited (IMPCL) amongst others are showcasing their strengths in research, education and development of such products.
"AYUSH is a very important sector and it should be propagated worldwide. MoUs have already been signed with several countries for bilateral cooperation in the field of traditional medicine.
"In view of the suggestions received, the National Health Policy would be reviewed in the next six months to incorporate this aspect of propagation of AYUSH. India is also entering into a very important partnership with the United States for research in AYUSH for treatment of cancer," AYUSH minister Shripad Yesso Naik said.
He was speaking after inaugurating the National Arogya Fair at Auto Cluster Development and Research Institute (ACDRI), PCMC, Chinchwad in Pune.
The Arogya fair aims to create awareness among the people about efficiency of the AYUSH Systems, their cost effectiveness and the availability of herbs and plants used for prevention and treatment of common ailments.
The fair is showcasing sectors like Ayurveda, Sidha, Naturopathy, Yoga, Unani, Homeopathy and other recognized traditional healthcare systems.
Institutions, companies associated with these areas of health care including insurance, health tourism, lab equipment and machinery, research institutes, hospitals, naturopathy centres are taking part in the event.
Central Research Councils and National Institute in the AYUSH Systems of Medicine along with the National Medicinal Plant Board (NMPB), Indian Medicines Pharmaceutical Corporations Limited (IMPCL) amongst others are showcasing their strengths in research, education and development of such products.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.